Interventions for Hypertrophic Obstructive Cardiomyopathy: Defining the Gold Standard, Assessing Durability, and Guiding Patient Selection
Medical Sciences · 2026
DOI: 10.3390/medsci14010109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, 2026. Verfasst von Ajibola Anifowose und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2G5, Canada. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Septal Myectomy. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic disorder characterized by a dynamic left ventricular outflow tract (LVOT) obstruction and an increased risk of sudden cardiac death. For patients with symptoms refractory to medical management, or intolerant to the new selective myosin inhibitor, septal reduction therapy (SRT) with surgical septal myectomy (SM) is indicated. This narrative review provides a contemporary assessment of septal myectomy, integrating its historical development, technical advancements, and comparative long-term outcomes. SM is established as the current reference standard, offering extensive anatomical relief and favorable long-term survival in clinical registries. It consistently achieves residual LVOT gradients 5 years). The disparity in long-term survival and the risk associated with sequential septal reduction procedures underscore the critical need for precise patient selection guided by institutional expertise. Furthermore, advancements like virtual surgical myectomy and transapical beating-heart septal myectomy are expanding the scope of intervention. This review synthesizes comparative contemporary data on HOCM management, highlighting the need for prospective, multicenter studies to address enduring knowledge gaps concerning equitable access, genotype integration, and long-term comparative effectiveness as current evidence remains dominated by retrospective studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2G5, Canada.
- Section of Cardiac Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Division of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, Calgary, AB T2N 1N4, Canada.
- Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, PA 19096, USA.
- Department of Cardiothoracic Surgery, Jena University Hospital, Friedrich Schiller University of Jena, 07747 Jena, Germany.
- Section of Cardiac Surgery, St. Boniface Hospital, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.
ORCID-Profile: Ajibola Anifowose, Marco Tagliafierro, Massimo Baudo, Tulio Caldonazo, Aleksander Dokollari, William D T Kent
Zitieren
APA
Anifowose, A., Tagliafierro, M., Mahdi, G., Hussein, S., Baudo, M., Caldonazo, T., Dokollari, A., Hosseini, K., Kent, W. D. T., & Fatehi Hassanabad, A. (2026). Interventions for Hypertrophic Obstructive Cardiomyopathy: Defining the Gold Standard, Assessing Durability, and Guiding Patient Selection. Medical Sciences. https://doi.org/10.3390/medsci14010109
Vancouver
Anifowose A, Tagliafierro M, Mahdi G, Hussein S, Baudo M, Caldonazo T, et al. Interventions for Hypertrophic Obstructive Cardiomyopathy: Defining the Gold Standard, Assessing Durability, and Guiding Patient Selection. Medical Sciences. 2026. doi:10.3390/medsci14010109
BibTeX
@article{Anifowose2026,
author = {Anifowose, Ajibola and Tagliafierro, Marco and Mahdi, Ghadeer and Hussein, Saada and Baudo, Massimo and Caldonazo, Tulio and Dokollari, Aleksander and Hosseini, Kaveh and Kent, William D T and Fatehi Hassanabad, Ali},
title = {Interventions for Hypertrophic Obstructive Cardiomyopathy: Defining the Gold Standard, Assessing Durability, and Guiding Patient Selection},
journal = {Medical Sciences},
year = {2026},
doi = {10.3390/medsci14010109}
}
EUVIMED